Table 2. Correlation between EphA2 and clinicopathologic features in 120 gastric cancer cases (χ2 test).
| Parameters | n | EphA2 | ||
|---|---|---|---|---|
| + | − | P-value | ||
| Age (years) | ||||
| <60 | 32 | 21 | 11 | 0.056 |
| ≥60 | 88 | 52 | 36 | |
| Gender | ||||
| Male | 61 | 39 | 22 | 0.314 |
| Female | 59 | 34 | 25 | |
| Size of tumor | ||||
| <5 cm | 64 | 31 | 33 | 0.061 |
| >5 cm | 56 | 42 | 14 | |
| ECOG score | ||||
| 0-1 | 58 | 34 | 24 | 0.219 |
| 2 | 62 | 39 | 23 | |
| Histologic type | ||||
| Well and moderate | 44 | 14 | 30 | 0.018 |
| Poor and undifferentiated | 76 | 59 | 17 | |
| CEA (ng/mL) | ||||
| <5 | 91 | 55 | 36 | 0.102 |
| ≥5 | 29 | 18 | 11 | |
ECOG: Eastern Cooperative Oncology Group; CEA: carcino-embryonic antigen.